Drugplain

Fentanyl Citrate 100 ug/2mL

Fentanyl Citrate · INJECTION, SOLUTION · Fresenius Kabi USA, LLC

10 Recalls on RecordCurrently in Shortage
Plain English

Fentanyl Citrate is a injection, solution containing fentanyl citrate at 100 ug/2mL, taken intramuscular. Manufactured by Fresenius Kabi USA, LLC.

Key Facts

Brand Name
Fentanyl Citrate
Generic Name
Fentanyl Citrate
NDC Code (Product)
63323-810
Manufacturer
Fresenius Kabi USA, LLC
Strength
100 ug/2mL
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS
Marketing Status
DEA Schedule
Schedule II (Controlled)
Application #
ANDA212086
Marketing Start
01/15/2021

Recall History

10 Recalls on Record
Class II05/05/2016

Pharmedium Services, LLC

Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

TerminatedVoluntary: Firm initiated
Class II07/25/2022

SterRx, LLC

Lack of Assurance of Sterility

TerminatedVoluntary: Firm initiated
Class II05/05/2016

Pharmedium Services, LLC

Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

TerminatedVoluntary: Firm initiated
Class I08/21/2015

Cantrell Drug Company

Subpotent Drug

TerminatedVoluntary: Firm initiated
Class II11/29/2022

OurPharma LLC

Underfilled units.

TerminatedVoluntary: Firm initiated
Class II03/22/2024

IntegraDose Compounding Services LLC

Lack of Assurance of Sterility: leaking bags

OngoingVoluntary: Firm initiated
Class II12/27/2017

Pharmedium Services, LLC

Lack of sterility assurance.

TerminatedVoluntary: Firm initiated
Class I12/28/2023

Denver Solutions, LLC DBA Leiters Health

Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

OngoingVoluntary: Firm initiated
Class II05/05/2016

Pharmedium Services, LLC

Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

TerminatedVoluntary: Firm initiated
Class II03/06/2025

QuVa Pharma, Inc.

Lack of Assurance of Sterility

OngoingVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

dependence3,935 reports
overdose2,444 reports
death2,060 reports
drug abuse1,730 reports
toxicity to various agents1,369 reports
ill-defined disorder1,288 reports
cardiac arrest913 reports
respiratory arrest737 reports
drug ineffective710 reports
drug hypersensitivity628 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

1 INDICATIONS AND USAGE Fentanyl Citrate Injection is indicated for: • analgesic action of short duration during the anesthetic periods, premedication, induction and maintenance, and in the immediate postoperative period (recovery room) as the need arises. • use as a narcotic analgesic supplement in general or regional anesthesia. • administration with a neuroleptic as an anesthetic premedication, for the induction of anesthesia and as an adjunct in the maintenance of general and regional anesthesia. • use as an anesthetic agent with oxygen in selected high-risk patients, such as those undergoing open heart surgery or certain complicated neurological or orthopedic procedures. Fentanyl Citrate Injection is indicated for: • analgesic action of short duration during the anesthetic periods, premedication, induction and maintenance, and in the immediate postoperative period (recovery room) as the need arises. • use as an opioid analgesic supplement in general or regional anesthesia. • administration with a neuroleptic as an anesthetic premedication, for the induction of anesthesia and as an adjunct in the maintenance of general and regional anesthesia. • use as an anesthetic agent with

Dosage & Administration

2 DOSAGE AND ADMINISTRATION • Fentanyl Citrate Injection should be administered only by persons specifically trained in the use of intravenous anesthetics and management of the respiratory effects of potent opioids. • Ensure that an opioid antagonist, resuscitative and intubation equipment, and oxygen are readily available ( 2.1 ). • Individualize dosing based on the factors such as age, body weight, physical status, underlying pathological condition, use of other drugs, type of anesthesia to be used, and the surgical procedure involved. ( 2.1 ) • Initiate treatment in adults with 50 mcg to 100 mcg. ( 2.2 ) • Initiate treatment in children 2 to 12 years of age, with a reduced dose as low as 2 mcg/kg to 3 mcg/kg. ( 2.2 ) 2.1 Important Dosage and Administration Instructions Fentanyl Citrate Injection should be administered only by persons specifically trained in the use of intravenous anesthetics and management of the respiratory effects of potent opioids. • Ensure that an opioid antagonist, resuscitative and intubation equipment, and oxygen are readily available. • Individualize dosage based on factors such as age, body weight, physical status, underlying pathological condition, use

Contraindications

4 CONTRAINDICATIONS Fentanyl Citrate Injection is contraindicated in patients with: • Hypersensitivity to fentanyl (e.g., anaphylaxis) [See Adverse Reactions ( 6 )] • Hypersensitivity to fentanyl ( 4 )

Drug Interactions

7 DRUG INTERACTIONS Table 2 includes clinically significant drug interactions with Fentanyl Citrate Injection. Table 2: Clinically Significant Drug Interactions with Fentanyl Citrate Injection Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Fentanyl Citrate Injection and CYP3A4 inhibitors can increase the plasma concentration of fentanyl, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of Fentanyl Citrate Injection is achieved [see Warnings and Precautions ( 5.4 )] . After stopping a CYP3A4 inhibitor, as the effects of the inhibitor decline, the fentanyl plasma concentration will decrease [see Clinical Pharmacology ( 12.3 )] , resulting in decreased opioid efficacy or a withdrawal syndrome in patients who had developed physical dependence to fentanyl. Intervention: If concomitant use is necessary, consider dosage reduction of Fentanyl Citrate Injection until stable drug effects are achieved [see Dosage and Administration ( 2.1 )] . Monitor patients at frequent intervals for respiratory depression and sedation. If a CYP3A4 inhibitor is discontinued, consider increasing the Fentanyl Citrate Injection dosage

Adverse Reactions

6 ADVERSE REACTIONS The following serious adverse reactions are described, or described in greater detail, in other sections: • Addiction, Abuse, and Misuse [see Warnings and Precautions ( 5.1 )] • Life-Threatening Respiratory Depression [see Warnings and Precautions ( 5.2 )] • Interactions with Benzodiazepines and Other CNS Depressants [see Warnings and Precautions ( 5.3 )] • Severe Cardiovascular Depression [see Warnings and Precautions ( 5.6 )] • Opioid-Induced Hyperalgesia and Allodynia [see Warnings and Precautions ( 5.7 )] • Serotonin Syndrome [see Warnings and Precautions ( 5.8 )] • Gastrointestinal Adverse Reactions [see Warnings and Precautions ( 5.11 )] • Seizures [see Warnings and Precautions ( 5.12 )] The following adverse reactions associated with the use of fentanyl were identified in clinical studies or postmarketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. As with other opioid agonists, the most common serious adverse reactions reported to occur with fentanyl are respiratory depression, apn

Frequently Asked Questions

What is Fentanyl Citrate used for?

Fentanyl Citrate contains Fentanyl Citrate. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.

Is Fentanyl Citrate a controlled substance?

Yes, Fentanyl Citrate is classified as CII under the DEA Controlled Substances Act.

What is the generic name for Fentanyl Citrate?

The generic name for Fentanyl Citrate is Fentanyl Citrate. There are no other listed brand versions of Fentanyl Citrate.

What is the NDC code for Fentanyl Citrate 100 ug/2mL?

The NDC (National Drug Code) for Fentanyl Citrate 100 ug/2mL is 63323-810, listed by Fresenius Kabi USA, LLC.